Crossmark

Stability Assessment of FDA Approved Varenicline Tartrate Products for Critical Quality Attributes – N-Nitroso Varenicline, Solid Form, and Dissolution

Crossref DOI link: https://doi.org/10.1208/s12249-026-03358-x

Published Online: 2026-04-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hassan, Mariame A.

Sibhat, Gereziher

Reddy, Indra K.

Khan, Mansoor A.

Rahman, Ziyaur https://orcid.org/0000-0002-0402-825X
License Information

Text and Data Mining valid from 2026-04-09

Version of Record valid from 2026-04-09
More Information

Article History

Received: 12 November 2025

Accepted: 25 January 2026

First Online: 9 April 2026

Declarations

:

: Authors report no conflict with the reported work.

Document is current

Any future updates will be listed below